AveGene AG

The core activity of AveGene is the development and implementation of genetic screening tests for the early detection of cancer and other diseases. The company offers various tests, including Somatic Multi-Cancer Early Detection, Colorectal + Lungs Cancer Early Detection, Oncogenic Agents - Heavy Metals, and HPV tests. The tests are based on the analysis of blood samples that can be taken by patients themselves at home. The results are then evaluated by AveGene and made available to patients and their doctors. The company emphasizes that its tests are not intended for diagnosis, but for early detection of diseases, and that the results should always be interpreted by a doctor.